Aberdeen Group’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,913
Closed -$2.75M 970
2024
Q4
$2.75M Sell
14,913
-13,006
-47% -$2.66M 0.01% 724
2024
Q3
$6.27M Sell
27,919
-5,149
-16% -$926K 0.01% 614
2024
Q2
$4.72M Buy
33,068
+11,930
+56% +$1.84M 0.01% 635
2024
Q1
$3.31M Hold
21,138
0.01% 727
2023
Q4
$3.81M Buy
21,138
+19,677
+1,347% +$3.56M 0.01% 714
2023
Q3
$263K Hold
1,461
﹤0.01% 861
2023
Q2
$260K Hold
1,461
﹤0.01% 886
2023
Q1
$315K Hold
1,461
﹤0.01% 870
2022
Q4
$321K Sell
1,461
-11,394
-89% -$2.09M ﹤0.01% 866
2022
Q3
$1.73M Buy
12,855
+2,345
+22% +$403K 0.01% 728
2022
Q2
$1.7M Buy
10,510
+6,018
+134% +$940K 0.01% 732
2022
Q1
$847K Sell
4,492
-49
-1% -$10.4K ﹤0.01% 843
2021
Q4
$1.23M Buy
4,541
+306
+7% +$103K ﹤0.01% 848
2021
Q3
$1.54M Buy
4,235
+230
+6% +$75.2K ﹤0.01% 831
2021
Q2
$1.37M Buy
4,005
+44
+1% +$14.6K ﹤0.01% 832
2021
Q1
$1.38M Buy
3,961
+915
+30% +$303K ﹤0.01% 822
2020
Q4
$787K Sell
3,046
-11,360
-79% -$3.13M ﹤0.01% 852
2020
Q3
$4.13M Buy
14,406
+1,106
+8% +$260K 0.01% 591
2020
Q2
$2.5M Buy
13,300
+180
+1% +$29.3K 0.01% 668
2020
Q1
$1.61M Buy
13,120
+881
+7% +$138K 0.01% 699
2019
Q4
$2.03M Sell
12,239
-2,282
-16% -$379K ﹤0.01% 722
2019
Q3
$1.78M Buy
14,521
+3,300
+29% +$438K ﹤0.01% 730
2019
Q2
$1.39M Buy
11,221
+900
+9% +$114K ﹤0.01% 789
2019
Q1
$1.36M Sell
10,321
-188
-2% -$25.4K ﹤0.01% 774
2018
Q4
$1.45M Buy
+10,509
New +$1.39M ﹤0.01% 727

Other funds holding ONC